Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Stomach Neoplasms | 17 | 2019 | 477 | 2.03 | Why? |
| Gastrectomy | 11 | 2019 | 225 | 1.39 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2021 | 665 | 0.68 | Why? |
| Tomography, X-Ray Computed | 17 | 2021 | 25144 | 0.63 | Why? |
| Perfusion Imaging | 2 | 2017 | 199 | 0.59 | Why? |
| Radiographic Image Enhancement | 1 | 2013 | 89 | 0.50 | Why? |
| Neovascularization, Pathologic | 1 | 2013 | 305 | 0.39 | Why? |
| Esophageal Neoplasms | 3 | 2018 | 357 | 0.37 | Why? |
| Radiation Dosage | 1 | 2013 | 585 | 0.36 | Why? |
| Esophagogastric Junction | 2 | 2018 | 30 | 0.36 | Why? |
| Laparoscopy | 5 | 2019 | 1532 | 0.34 | Why? |
| Adenocarcinoma | 3 | 2019 | 651 | 0.33 | Why? |
| Magnetic Resonance Imaging | 3 | 2021 | 6551 | 0.33 | Why? |
| Lymph Nodes | 3 | 2018 | 1060 | 0.32 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2021 | 869 | 0.32 | Why? |
| Neoplasm Staging | 6 | 2019 | 1999 | 0.31 | Why? |
| Community-Acquired Infections | 5 | 2021 | 2328 | 0.31 | Why? |
| Radiography, Thoracic | 4 | 2020 | 5486 | 0.30 | Why? |
| Cell Movement | 3 | 2018 | 695 | 0.30 | Why? |
| Lymphatic Metastasis | 4 | 2019 | 537 | 0.27 | Why? |
| Lung Neoplasms | 3 | 2017 | 3228 | 0.25 | Why? |
| Lung | 5 | 2021 | 31049 | 0.20 | Why? |
| 3' Untranslated Regions | 2 | 2018 | 318 | 0.19 | Why? |
| Anastomosis, Roux-en-Y | 1 | 2018 | 24 | 0.19 | Why? |
| Diagnosis, Computer-Assisted | 2 | 2021 | 436 | 0.19 | Why? |
| Garlic | 1 | 2018 | 43 | 0.19 | Why? |
| Tenascin | 1 | 2017 | 8 | 0.18 | Why? |
| Annexin A2 | 1 | 2017 | 13 | 0.18 | Why? |
| Meningitis, Cryptococcal | 1 | 2018 | 79 | 0.18 | Why? |
| Receptors, Adiponectin | 1 | 2017 | 6 | 0.18 | Why? |
| Neoplastic Cells, Circulating | 1 | 2018 | 68 | 0.18 | Why? |
| Carcinoma, Non-Small-Cell Lung | 2 | 2017 | 896 | 0.17 | Why? |
| Image Processing, Computer-Assisted | 3 | 2021 | 1383 | 0.17 | Why? |
| Membrane Microdomains | 1 | 2017 | 51 | 0.16 | Why? |
| Neovascularization, Physiologic | 1 | 2017 | 160 | 0.16 | Why? |
| Neoplasm Invasiveness | 1 | 2018 | 582 | 0.15 | Why? |
| Helicobacter Infections | 1 | 2018 | 216 | 0.15 | Why? |
| Imaging, Three-Dimensional | 1 | 2020 | 680 | 0.14 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.14 | Why? |
| MicroRNAs | 2 | 2018 | 1787 | 0.14 | Why? |
| Medical Records | 1 | 2017 | 513 | 0.13 | Why? |
| Reproducibility of Results | 4 | 2021 | 11304 | 0.13 | Why? |
| Cell Proliferation | 2 | 2018 | 1973 | 0.13 | Why? |
| Blood Flow Velocity | 1 | 2013 | 193 | 0.12 | Why? |
| Postoperative Complications | 4 | 2019 | 5861 | 0.12 | Why? |
| Tumor Burden | 3 | 2017 | 369 | 0.11 | Why? |
| Chemotherapy, Adjuvant | 3 | 2019 | 606 | 0.11 | Why? |
| Neoadjuvant Therapy | 3 | 2019 | 554 | 0.11 | Why? |
| Encephalitis | 1 | 2018 | 797 | 0.11 | Why? |
| Pneumonia, Viral | 12 | 2021 | 243684 | 0.11 | Why? |
| Middle Aged | 27 | 2021 | 270681 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Disease-Free Survival | 3 | 2018 | 1654 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Female | 28 | 2021 | 380317 | 0.09 | Why? |
| Stomach | 2 | 2019 | 141 | 0.09 | Why? |
| Male | 27 | 2021 | 367725 | 0.09 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.08 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.08 | Why? |
| Humans | 41 | 2021 | 930598 | 0.08 | Why? |
| Retrospective Studies | 15 | 2021 | 105322 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Adult | 18 | 2021 | 244371 | 0.08 | Why? |
| Aged | 20 | 2021 | 215776 | 0.08 | Why? |
| Lymph Node Excision | 2 | 2018 | 362 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Survival Rate | 4 | 2019 | 9206 | 0.06 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| China | 8 | 2020 | 50654 | 0.06 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.05 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.05 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.05 | Why? |
| Survival Analysis | 3 | 2019 | 7592 | 0.05 | Why? |
| Follow-Up Studies | 4 | 2020 | 17020 | 0.05 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.05 | Why? |
| Gastroenterostomy | 1 | 2018 | 5 | 0.05 | Why? |
| Algorithms | 3 | 2021 | 7346 | 0.05 | Why? |
| Combined Modality Therapy | 2 | 2018 | 3395 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Capecitabine | 1 | 2018 | 51 | 0.05 | Why? |
| Voluntary Health Agencies | 1 | 2017 | 7 | 0.05 | Why? |
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 67 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.04 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1573 | 0.04 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2018 | 99 | 0.04 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 92 | 0.04 | Why? |
| Treatment Outcome | 6 | 2020 | 51732 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.04 | Why? |
| Anastomotic Leak | 1 | 2017 | 46 | 0.04 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.04 | Why? |
| Clone Cells | 1 | 2017 | 312 | 0.04 | Why? |
| Health Status Indicators | 1 | 2020 | 341 | 0.04 | Why? |
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 96 | 0.04 | Why? |
| MCF-7 Cells | 1 | 2017 | 199 | 0.04 | Why? |
| Microsatellite Repeats | 1 | 2017 | 99 | 0.04 | Why? |
| RAW 264.7 Cells | 1 | 2017 | 316 | 0.04 | Why? |
| Repressor Proteins | 1 | 2018 | 232 | 0.04 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2021 | 669 | 0.04 | Why? |
| Pain Measurement | 1 | 2019 | 533 | 0.04 | Why? |
| Exome | 1 | 2017 | 207 | 0.04 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2017 | 400 | 0.04 | Why? |
| Diagnosis, Differential | 2 | 2021 | 7220 | 0.04 | Why? |
| Chemoradiotherapy | 1 | 2018 | 362 | 0.04 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.04 | Why? |
| Helicobacter pylori | 1 | 2018 | 262 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2018 | 801 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.04 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.04 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 291 | 0.04 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.03 | Why? |
| Aorta | 1 | 2017 | 355 | 0.03 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.03 | Why? |
| Mutation Rate | 1 | 2017 | 382 | 0.03 | Why? |
| Databases, Factual | 2 | 2020 | 6248 | 0.03 | Why? |
| Datasets as Topic | 1 | 2020 | 1404 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.03 | Why? |
| Plaque, Atherosclerotic | 1 | 2017 | 423 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.03 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 952 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.03 | Why? |
| Propensity Score | 1 | 2019 | 2690 | 0.03 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.02 | Why? |
| Biopsy | 1 | 2019 | 2811 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Endoscopy | 1 | 2018 | 1564 | 0.02 | Why? |
| Mutation | 2 | 2017 | 12376 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Computational Biology | 1 | 2020 | 4514 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Hypoxia | 1 | 2017 | 3626 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Registries | 1 | 2017 | 12327 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Shan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(208)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_